CancerVision
Solid Tumor Cancers
CommercialActive
Key Facts
About Inocras
Inocras is a commercial-stage diagnostics and services company leveraging whole genome sequencing (WGS) and advanced bioinformatics to provide actionable insights in oncology and rare disease. Its core offerings include CancerVision for solid tumors, MRDVision for minimal residual disease detection, and RareVision for rare genetic disorders, all delivered through a CAP/CLIA lab with a two-week turnaround. The company serves patients, healthcare providers, and researchers, positioning itself at the intersection of clinical diagnostics and genomic research services.
View full company profileTherapeutic Areas
Other Solid Tumor Cancers Drugs
| Drug | Company | Phase |
|---|---|---|
| TP-317 | Thetis Pharmaceuticals | Preclinical/Undisclosed |
| Undisclosed Bispecific ADC Pipeline | NEOK Bio | Pre-clinical |
| Mini-CAR for Solid Tumors | Caravan Biologix | Pre-clinical |